PROMab Trial: Ampicillin With or Without Gentamicin for Term Prelabour Rupture of Membranes
A legfontosabb adatok
- Ki végzi
- Sarawak General Hospital
- Hol
- Malajzia3 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toborzás még nem indult
- Fázis
- 4. fázis
- Résztvevők
- 320 fő, tervezett
- Kezdés
- 2026. júl. 1.
- Várható befejezés
- 2027. márc. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Ampicillin
- Ampicillin + gentamicin
- A regiszteradat frissítve
- 2026. május 4.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Csak nők
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 26 feltétel megnézéseKevesebb
Ki vehet részt
- Age 18 years or older
- Singleton pregnancy
- Cephalic (vertex) presentation
- Term gestation of 37+0 weeks or more based on obstetric dating
- Confirmed prelabour rupture of membranes
- Duration of prelabour rupture of membranes 12 hours or less at the time of enrolment
- Unknown or negative Group B Streptococcus status in the current pregnancy
- Clear amniotic fluid at presentation
- Afebrile with no clinical signs of intra-amniotic infection at admission
- Able to provide written informed consent
- Planned delivery at a participating study hospital
Ki nem vehet részt
- Fever of 38.0°C or higher, maternal tachycardia, uterine tenderness, purulent discharge, or other clinical suspicion of infection at admission
- Allergy or contraindication to penicillin or aminoglycosides
- Known renal disease
- Known ototoxicity risk or vestibular/cochlear disorders
- Renal impairment defined as creatinine clearance less than 30 mL/min
- Preterm prelabour rupture of membranes before 37+0 weeks
- Antibiotics already initiated in the current episode of care for any reason
- Receipt of systemic antibiotics in the past 7 days
- Meconium-stained liquor at presentation
- Contraindication to vaginal delivery, including malpresentation, major placenta praevia, maternal refusal of trial of labour after caesarean, or known absolute indication for elective lower segment caesarean section
- Known Group B Streptococcus colonisation in the current pregnancy, including positive rectovaginal swab or bacteriuria
- Abnormal cardiotocography on admission requiring expedited delivery
- Unknown timing of prelabour rupture of membranes
- Multiple gestation
- Major fetal anomaly
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to learn whether adding gentamicin to standard ampicillin prophylaxis can better prevent clinical chorioamnionitis and other maternal and neonatal infectious complications in pregnant women aged 18 years or older with singleton, cephalic, term pregnancies and confirmed prelabour rupture of membranes. The main questions it aims to answer are:
A teljes eredeti leírásKevesebb
Does ampicillin plus gentamicin reduce the incidence of clinical chorioamnionitis compared with ampicillin alone? Does ampicillin plus gentamicin improve maternal infectious outcomes and neonatal infection-related outcomes compared with ampicillin alone?
Researchers will compare ampicillin alone with ampicillin plus gentamicin to see whether broader antibiotic coverage reduces maternal and neonatal infectious morbidity.
Participants will:
1. undergo screening and eligibility assessment 2. provide written informed consent before randomisation 3. be randomly assigned to receive either intravenous ampicillin alone or intravenous ampicillin plus gentamicin 4. start study antibiotics at 12 hours after membrane rupture and continue treatment until delivery 5. undergo routine maternal and fetal monitoring during labour and delivery have maternal and neonatal outcomes assessed during hospital stay and up to 42 days postpartum, including telephone follow-up at Day 14 and Day 42 6. optionally consent to placental tissue collection for microbiological culture at delivery
A vizsgálat 2 csoportja
- Ampicillin AloneMár használt kezelés, összehasonlításként
Participants randomized to this arm will receive intravenous ampicillin 2 g stat, followed by intravenous ampicillin 1 g every 4 hours. Study antibiotics will be initiated at 12 hours after prelabour rupture of membranes and continued until delivery. If clinical chorioamnionitis develops, study prophylaxis will be discontinued and therapeutic antibiotics will be started according to local hospital protocol.
Kezelés: Ampicillin
- Ampicillin Plus GentamicinA vizsgált kezelés
Participants randomized to this arm will receive intravenous ampicillin 2 g stat, followed by intravenous ampicillin 1 g every 4 hours, plus intravenous gentamicin 5 mg/kg once daily. Study antibiotics will be initiated at 12 hours after prelabour rupture of membranes and continued until delivery. Gentamicin will only be administered to participants with baseline creatinine clearance of 30 mL/min or higher. If clinical chorioamnionitis develops, study prophylaxis will be discontinued and therapeutic antibiotics will be started according to local hospital protocol
Kezelés: Ampicillin + gentamicin
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Term Prelabour Rupture of Membranes Antibiotic Prophylaxis (PROMab) Trial
- A regiszteradat frissítve
- 2026. május 4.